AEye Reports Third Quarter 2025 Results
Doubled customer base, fueling expansion across high-growth markets
Secured strategic investment to significantly expand Apollo production capacity
Recent Business Highlights
- Captured six new business wins since end of Q2, with 12 customer contracts signed year-to-date
- Secured strategic investment with leading global investor to expand Tier-1 manufacturing partnership and scale Apollo production to 60,000 units annually
- Delivered Apollo units to a global defense contractor powering next-generation aerial systems
- New revenue-generating partnerships are accelerating commercial traction for Apollo and OPTIS™, including collaborations with Black Sesame Technologies, Blue-Band, and Flasheye
- Achieved strong capital position and virtually debt-free balance sheet, supporting operational runway well into 2028
Management Commentary
“AEye delivered a milestone quarter defined by execution, commercialization, and expansion,” said
“We also advanced our strategic partnerships with Black Sesame Technologies, Blue-Band, and Flasheye, extending our reach into global autonomous mobility, rail, and smart-infrastructure markets. In parallel, we expanded our manufacturing footprint through an investment from a leading institutional investor to enable annual production capacity of up to 60,000 Apollo units with our Tier-1 partner. With our technology, partnerships, and financial foundation firmly in place,
Recent Financial Highlights
-
Cash burn excluding net financing proceeds in Q3 2025 was
$6.4 million -
GAAP net loss in Q3 2025 was
$(9.3) million , or$(0.30) per share, based on 31.3 million weighted average common shares outstanding -
Non-GAAP net loss in Q3 2025 was
$(5.4) million , or$(0.17) per share, based on 31.3 million weighted average common shares outstanding -
Cash, cash equivalents, and marketable securities were
$84.3 million as ofSeptember 30, 2025 , quadruple compared to the end of the prior quarter
“We continued to execute with financial discipline in the third quarter, maintaining one of the strongest balance sheets among our peers, with virtually no debt,” said
2025 Financial Outlook
Conference Call and Webcast Details
The webcast and accompanying slides will be accessible via the company’s website at https://investors.aeye.ai/.
Access is also available via:
Webcast: https://aeye.pub/48vlnTU
About
Non-GAAP Financial Measures
The non-GAAP measures provided in this press release should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with generally accepted accounting principles (GAAP) in
This press release includes the following non-GAAP financial measures:
- Non-GAAP net loss which is defined as GAAP net loss plus stock-based compensation, plus stock issuance and debt issuance costs, plus change in fair value of convertible note and warrant liabilities, plus expenses related to contested proxy, plus loss (gain) on termination of operating lease, net; and
- Adjusted EBITDA, defined as non-GAAP net loss plus depreciation and amortization expense, less interest income and other, less interest expense and other, plus provision for income tax.
Forward-Looking Statements
Certain statements included in this press release that are not historical facts are forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are sometimes accompanied by words such as “believe,” “continue,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “predict,” “plan,” “may,” “should,” “will,” “would,” “potential,” “seem,” “seek,” “outlook,” and similar expressions that predict or indicate future events or trends, or that are not statements of historical matters. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Forward-looking statements in this press release include, without limitation, statements about the expansion of manufacturing capacity to 60,000 Apollo units per year, management’s belief that commercial traction for the Apollo product is accelerating and market confidence is growing in many markets, the Company’s expected cash burn for full year 2025, and the Company’s expectation that its operational runway extends into 2028, among others. These statements are based on various assumptions, whether or not identified in this press release. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are very difficult or impossible to predict and will differ from the assumptions. Many actual events and circumstances are beyond the control of
Readers are cautioned not to put undue reliance on forward-looking statements;
|
Consolidated Balance Sheets (In thousands) (Unaudited) |
|||||
| As of |
As of |
||||
| ASSETS | |||||
| Current Assets: | |||||
| Cash and cash equivalents |
$ |
43,035 |
$ |
10,266 |
|
| Marketable securities |
|
41,298 |
|
12,012 |
|
| Accounts receivable, net |
|
56 |
|
11 |
|
| Inventories, net |
|
884 |
|
176 |
|
| Prepaid and other current assets |
|
935 |
|
2,706 |
|
| Total current assets |
|
86,208 |
|
25,171 |
|
| Right-of-use assets |
|
495 |
|
652 |
|
| Property and equipment, net |
|
549 |
|
605 |
|
| Other noncurrent assets |
|
296 |
|
692 |
|
| Total assets |
$ |
87,548 |
$ |
27,120 |
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||
| Current Liabilities: | |||||
| Accounts payable |
$ |
4,471 |
$ |
3,598 |
|
| Accrued expenses and other current liabilities |
|
3,508 |
|
7,709 |
|
| Convertible note, current |
|
106 |
|
- |
|
| Total current liabilities |
|
8,085 |
|
11,307 |
|
| Operating lease liabilities, noncurrent |
|
299 |
|
479 |
|
| Convertible note, noncurrent |
|
146 |
|
146 |
|
| Other noncurrent liabilities |
|
826 |
|
64 |
|
| Total liabilities |
|
9,356 |
|
11,996 |
|
| Stockholders’ Equity: | |||||
| Preferred stock |
|
- |
|
- |
|
| Common stock |
|
4 |
|
1 |
|
| Additional paid-in capital |
|
477,903 |
|
388,213 |
|
| Accumulated other comprehensive income (loss) |
|
(4) |
|
5 |
|
| Accumulated deficit |
|
(399,711) |
|
(373,095) |
|
| Total stockholders’ equity |
|
78,192 |
|
15,124 |
|
| Total liabilities and stockholders’ equity |
$ |
87,548 |
$ |
27,120 |
|
|
Consolidated Statements of Operations (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||
| Three months ended |
Nine months ended |
||||||||||
|
2025 |
2024 |
2025 |
2024 |
||||||||
| Revenue |
$ |
50 |
$ |
104 |
$ |
136 |
$ |
156 |
|||
| Cost of revenue |
|
103 |
|
306 |
|
307 |
|
729 |
|||
| Gross loss |
|
(53) |
|
(202) |
|
(171) |
|
(573) |
|||
| Operating expenses: | |||||||||||
| Research and development |
|
3,061 |
|
3,767 |
|
10,221 |
|
12,137 |
|||
| Sales and marketing |
|
631 |
|
74 |
|
1,615 |
|
482 |
|||
| General and administrative |
|
4,080 |
|
3,803 |
|
11,323 |
|
13,641 |
|||
| Total operating expenses |
|
7,772 |
|
7,644 |
|
23,159 |
|
26,260 |
|||
| Loss from operations |
|
(7,825) |
|
(7,846) |
|
(23,330) |
|
(26,833) |
|||
| Other income (expense): | |||||||||||
| Change in fair value of convertible note and warrant liabilities |
|
(2,210) |
|
9 |
|
(2,123) |
|
(4) |
|||
| Interest income and other |
|
650 |
|
233 |
|
1,257 |
|
656 |
|||
| Interest expense and other |
|
55 |
|
(1,102) |
|
(2,418) |
|
(729) |
|||
| Total other income (expense), net |
|
(1,505) |
|
(860) |
|
(3,284) |
|
(77) |
|||
| Loss before income tax |
|
(9,330) |
|
(8,706) |
|
(26,614) |
|
(26,910) |
|||
| Provision for income tax |
|
- |
|
- |
|
2 |
|
2 |
|||
| Net loss |
$ |
(9,330) |
$ |
(8,706) |
$ |
(26,616) |
$ |
(26,912) |
|||
| Per Share Data | |||||||||||
| Net loss per common share (basic and diluted) |
$ |
(0.30) |
$ |
(1.01) |
$ |
(1.34) |
$ |
(3.90) |
|||
| Weighted average common shares outstanding (basic and diluted) |
|
31,262,997 |
|
8,629,683 |
|
19,880,145 |
|
6,892,910 |
|||
|
Consolidated Statements of Cash Flows (In thousands) (Unaudited) |
|||||
| Nine months ended |
|||||
|
2025 |
2024 |
||||
| Cash flows from operating activities: | |||||
| Net loss |
$ |
(26,616) |
$ |
(26,912) |
|
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization |
|
113 |
|
80 |
|
| Gain on sale of property and equipment |
|
- |
|
(12) |
|
| Noncash lease expense relating to operating lease right-of-use assets |
|
157 |
|
905 |
|
| Gain on termination of operating lease, net |
|
(1,014) |
|
(680) |
|
| Common stock purchase agreement costs |
|
325 |
|
1,136 |
|
| Debt issuance costs |
|
2,020 |
|
- |
|
| Gain on extinguishment of warrant |
|
(64) |
|
- |
|
| Inventory write-downs, net of scrapped inventory |
|
24 |
|
167 |
|
| Change in fair value of convertible note and warrant liabilities |
|
2,123 |
|
4 |
|
| Stock-based compensation |
|
4,732 |
|
7,002 |
|
| Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest |
|
(180) |
|
(491) |
|
| Expected credit losses, net of write-off |
|
2 |
|
35 |
|
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net |
|
(47) |
|
20 |
|
| Inventories, current and noncurrent, net |
|
(523) |
|
157 |
|
| Prepaid and other current assets |
|
92 |
|
1,035 |
|
| Other noncurrent assets |
|
187 |
|
123 |
|
| Accounts payable |
|
800 |
|
275 |
|
| Accrued expenses and other current liabilities |
|
(804) |
|
(3,411) |
|
| Operating lease liabilities |
|
(1,574) |
|
(936) |
|
| Contract liabilities |
|
- |
|
35 |
|
| Other noncurrent liabilities |
|
- |
|
(346) |
|
| Net cash used in operating activities |
|
(20,247) |
|
(21,814) |
|
| Cash flows from investing activities: | |||||
| Purchases of property and equipment |
|
(52) |
|
(420) |
|
| Proceeds from sale of property and equipment |
|
- |
|
45 |
|
| Purchases of marketable securities |
|
(44,989) |
|
(24,241) |
|
| Proceeds from redemptions and maturities of marketable securities |
|
15,874 |
|
27,756 |
|
| Net cash (used in) provided by investing activities |
|
(29,167) |
|
3,140 |
|
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options |
|
- |
|
134 |
|
| Proceeds from issuance of convertible note |
|
2,950 |
|
146 |
|
| Payments for convertible note redemptions |
|
(989) |
|
- |
|
| Transaction costs related to issuance of convertible note |
|
(658) |
|
- |
|
| Proceeds from issuance of common stock under Common Stock Purchase Agreements |
|
80,988 |
|
5,863 |
|
| Stock issuance costs related to Common Stock Purchase Agreements |
|
(1,449) |
|
(613) |
|
| Taxes paid related to the net share settlement of equity awards |
|
(499) |
|
(113) |
|
| Proceeds from exercise of warrant |
|
1,788 |
|
- |
|
| Proceeds from issuance of common stock through the Employee Stock Purchase Plan |
|
52 |
|
26 |
|
| Net cash provided by financing activities |
|
82,183 |
|
5,443 |
|
| Net increase (decrease) in cash, cash equivalents and restricted cash |
|
32,769 |
|
(13,231) |
|
| Cash, cash equivalents and restricted cash at beginning of period |
|
10,266 |
|
19,082 |
|
| Cash, cash equivalents and restricted cash at end of period |
$ |
43,035 |
$ |
5,851 |
|
|
Reconciliation of GAAP to Non-GAAP Financial Measures (In thousands, except share amounts and per share data) (Unaudited) |
|||||||||||
| Three months ended |
Nine months ended |
||||||||||
|
2025 |
2024 |
2025 |
2024 |
||||||||
| GAAP net loss |
$ |
(9,330) |
$ |
(8,706) |
$ |
(26,616) |
$ |
(26,912) |
|||
| Non-GAAP adjustments: | |||||||||||
| Stock-based compensation |
|
1,071 |
|
2,248 |
|
4,732 |
|
7,002 |
|||
| Stock issuance and debt issuance costs |
|
19 |
|
1,136 |
|
2,345 |
|
1,136 |
|||
| Change in fair value of convertible note and warrant liabilities |
|
2,210 |
|
(9) |
|
2,123 |
|
4 |
|||
| Expenses related to contested proxy |
|
- |
|
- |
|
839 |
|
- |
|||
| Loss (gain) on termination of operating lease, net |
|
598 |
|
(680) |
|
(1,014) |
|
(680) |
|||
| Non-GAAP net loss |
|
(5,432) |
|
(6,011) |
|
(17,591) |
|
(19,450) |
|||
| Depreciation and amortization expense |
|
38 |
|
24 |
|
113 |
|
80 |
|||
| Interest income and other |
|
(650) |
|
(233) |
|
(1,257) |
|
(656) |
|||
| Interest expense and other |
|
(74) |
|
(34) |
|
73 |
|
(407) |
|||
| Provision for income tax |
|
- |
|
- |
|
2 |
|
2 |
|||
| Adjusted EBITDA |
$ |
(6,118) |
$ |
(6,254) |
$ |
(18,660) |
$ |
(20,431) |
|||
| GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
$ |
(0.30) |
$ |
(1.01) |
$ |
(1.34) |
$ |
(3.90) |
|||
| Non-GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
$ |
(0.17) |
$ |
(0.70) |
$ |
(0.88) |
$ |
(2.82) |
|||
| Shares used in computing GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
|
31,262,997 |
|
8,629,683 |
|
19,880,145 |
|
6,892,910 |
|||
| Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | |||||||||||
| Basic and diluted |
|
31,262,997 |
|
8,629,683 |
|
19,880,145 |
|
6,892,910 |
|||
View source version on businesswire.com: https://www.businesswire.com/news/home/20251106240466/en/
Investor Relations Contacts:
Agency Contact
Financial
eniu@finprofiles.com
310-622-8243
Company Contact
info@aeye.ai
925-400-4366
Source: